Publication: Macroscopic Portal Vein Thrombosis in HCC Patients
| dc.authorscopusid | 6603439422 | |
| dc.authorscopusid | 57217614267 | |
| dc.authorscopusid | 8653680300 | |
| dc.authorscopusid | 57193124450 | |
| dc.authorscopusid | 6507912704 | |
| dc.authorscopusid | 55601927500 | |
| dc.authorscopusid | 6602864261 | |
| dc.contributor.author | Akkız, H. | |
| dc.contributor.author | Carr, B.I. | |
| dc.contributor.author | Kuran, S. | |
| dc.contributor.author | Karaoǧullarindan, Ü. | |
| dc.contributor.author | Üsküdar, O. | |
| dc.contributor.author | Tokmak, S. | |
| dc.contributor.author | Arslan, B. | |
| dc.date.accessioned | 2020-06-21T13:13:10Z | |
| dc.date.available | 2020-06-21T13:13:10Z | |
| dc.date.issued | 2018 | |
| dc.department | Ondokuz Mayıs Üniversitesi | en_US |
| dc.department-temp | [Akkız] Hikmet, Çukurova Üniversitesi, Adana, Adana, Turkey; [Carr] Brian Irving, Izmir International Biomedicine and Genome Institute, Dokuz Eylül Üniversitesi, Izmir, Turkey; [Kuran] Sedef Özdal, Çukurova Üniversitesi, Adana, Adana, Turkey; [Karaoǧullarindan] U., Çukurova Üniversitesi, Adana, Adana, Turkey; [Üsküdar] Oǧuz, Çukurova Üniversitesi, Adana, Adana, Turkey; [Tokmak] Salih, Çukurova Üniversitesi, Adana, Adana, Turkey; [Arslan] Burcu, Çukurova Üniversitesi, Adana, Adana, Turkey; [Doran] Figen, Çukurova Üniversitesi, Adana, Adana, Turkey; [Balli] Huseyin Tuğsan, Çukurova Üniversitesi, Adana, Adana, Turkey; [Ülkü] Abdulalh, Çukurova Üniversitesi, Adana, Adana, Turkey; [Akcam] Atilgan Tolga, Çukurova Üniversitesi, Adana, Adana, Turkey; [Bahçeci] Halil Ibrahim, Firat Üniversitesi, Elazig, Turkey; [Polat] Kamil Yalçin, Istanbul Memorial Hospital, Okmeydani, Istanbul, Turkey; [Örmeci] Necati, Ankara Üniversitesi, Ankara, Turkey; [Simsek] Halis, Hacettepe Üniversitesi, Ankara, Turkey; [Sonsuz] Abdullah, Istanbul Üniversitesi, Istanbul, Turkey; [Demir] Ali, Necmettin Erbakan Üniversitesi, Meram, Konya, Turkey; [Altıntaş] Engin, Mersin Üniversitesi, Mersin, Turkey; [Demir] Mehmet Akif, Mustafa Kemal Üniversitesi, Antakya, Turkey; [Yalçin] Kendal, Dicle Üniversitesi, Diyarbakir, Diyarbakir, Turkey; [Ekinci] Nazlm, Dicle Üniversitesi, Diyarbakir, Diyarbakir, Turkey; [Özakyol] Ayşegül Harmanci, Eskişehir Osmangazi Üniversitesi, Eskisehir, Eskisehir, Turkey; [Yücesoy] Mehmet Ali, Erciyes Üniversitesi, Kayseri, Kayseri, Turkey; [Uygun] Ahmet, Sultan 2.Abdülhamid Han Eğitim ve Araştirma Hastanesi, Uskudar, Istanbul, Turkey; [Guerra] Vito M.B., IRCCS Saverio de Bellis, Castellana Grotte, BA, Italy; [Delik] Anıl, Çukurova Üniversitesi, Adana, Adana, Turkey; [Tokat] Yaman, Florence Nightingale Hospital, Istanbul, Turkey; [Yilmaz] Sezai, Inönü Üniversitesi, Malatya, Turkey; [Bektaş] Ahmet Fırat, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Kilic] Murat, Izmir Kent Hospital, Kent, Turkey | en_US |
| dc.description.abstract | Macroscopic portal vein invasion (PVT) by hepatocellular carcinoma (HCC) in the liver is one of the most important negative prognostic factors for HCC patients. The characteristics of a large cohort of such patients were examined. We found that the percent of patients with PVT significantly increased with increasing maximum tumor diameter (MTD), from 13.7% with tumors of MTD <5cm to 56.4% with tumors of MTD >10cm. There were similar numbers of HCC patients with very large tumors with and without PVT. Thus, MTD alone was insufficient to explain the presence of PVT, as were high AFP levels, since less than 50% of high AFP patients had PVT. However, the percent of patients with PVT was also found to significantly increase with increasing blood alpha-fetoprotein (AFP) levels and tumor multifocality. A logistic regression model that included these 3 factors together showed an odds ratio of 17.9 for the combination of MTD>5.0cm plus tumor multifocality plus elevated AFP, compared to low levels of these 3 parameters. The presence or absence of macroscopic PVT may therefore represent different HCC aggressiveness phenotypes, as judged by a significant increase in tumor multifocality and AFP levels in the PVT positive patients. Factors in addition to MTD and AFP must also contribute to PVT development. © 2018 Hikmet Akkiz et al. | en_US |
| dc.identifier.doi | 10.1155/2018/3120185 | |
| dc.identifier.issn | 2291-2789 | |
| dc.identifier.issn | 2291-2797 | |
| dc.identifier.pmid | 30009156 | |
| dc.identifier.scopus | 2-s2.0-85049358746 | |
| dc.identifier.scopusquality | Q2 | |
| dc.identifier.uri | https://doi.org/10.1155/2018/3120185 | |
| dc.identifier.volume | 2018 | en_US |
| dc.identifier.wos | WOS:000436297600001 | |
| dc.identifier.wosquality | Q3 | |
| dc.language.iso | en | en_US |
| dc.publisher | Hindawi Limited 410 Park Avenue, 15th Floor, 287 pmb New York NY 10022 | en_US |
| dc.relation.ispartof | Canadian Journal of Gastroenterology and Hepatology | en_US |
| dc.relation.journal | Canadian Journal of Gastroenterology and Hepatology | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.title | Macroscopic Portal Vein Thrombosis in HCC Patients | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication |
